Tokyo Tape
Sign in
← Takeda Pharmaceutical

Annual report

4502.TEDINET S100OBQE
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥3.20T2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥3.29T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥2.10T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.77T2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥460.8bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥509.3bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥366.2bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax−¥60.8bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥127.6bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥217.2bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥376.0bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥44.2bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥135.2bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥186.9bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥376.2bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Net income¥44.3bn2019-04-01 → 2020-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥135.1bn2018-04-01 → 2019-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥186.7bn2017-04-01 → 2018-03-31dCons.Profit loss IFRS (5-year summary)
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.91Tat 2021-03-31Cons.Assets IFRS
Total assets¥12.82Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥13.79Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥4.11Tat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥7.74Tat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31Cons.Equity IFRS
Net assets / equity¥4.73Tat 2020-03-31dCons.Equity IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.17Tat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥637.6bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥702.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥294.5bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.01T2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥669.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥328.5bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥377.9bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥393.5bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥292.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.84T2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥93.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.09T2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.01T2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥2.95T2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥326.2bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥240.722020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥28.412019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥140.612018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥239.352017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥238.962020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥28.252019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥139.822018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥237.562017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥3,665.61at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,308.93at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,032.22at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,332.94at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥2,556.51at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio40.1%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.8%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.6%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE4.2%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.6%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE0.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE3.8%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.6%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees47,347at 2022-03-31Cons.Number of employees
Employees47,099at 2021-03-31Cons.Number of employees
Employees47,495at 2020-03-31dCons.Number of employees
Employees49,578at 2019-03-31dCons.Number of employees
Employees27,230at 2018-03-31dCons.Number of employees
Revenue¥764.3bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥602.6bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥616.3bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥651.3bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥659.5bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥293.7bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥121.1bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥550.9bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥50.0bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥72.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥17.5bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥125.9bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥371.9bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥235.5bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥324.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥247.5bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥130.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥88.2bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥187.0bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥9.64Tat 2022-03-31StandaloneAssets
Total assets¥10.86Tat 2021-03-31StandaloneAssets
Total assets¥10.29Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥9.53Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.95Tat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥5.35Tat 2022-03-31StandaloneLiabilities
Total liabilities¥6.42Tat 2021-03-31StandaloneLiabilities
Net assets / equity¥4.29Tat 2022-03-31StandaloneNet assets
Net assets / equity¥4.43Tat 2021-03-31StandaloneNet assets
Net assets / equity¥4.55Tat 2020-03-31dStandaloneNet assets
Net assets / equity¥4.65Tat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.57Tat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥287.1bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥274.0bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥207.52021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥158.452020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.882019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥91.762018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥239.472017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥207.52021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥158.442020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥83.872019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥91.722018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥239.182017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1802021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,769.31at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,835.81at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,919.21at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,987.94at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,002.29at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.2%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio53.1%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE7.4%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE5.5%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE2.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.8%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE12.1%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,582,253,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,388,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,374,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,565,006,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued794,688,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees5,149at 2022-03-31StandaloneNumber of employees
Employees4,966at 2021-03-31StandaloneNumber of employees
Employees5,350at 2020-03-31dStandaloneNumber of employees
Employees5,291at 2019-03-31dStandaloneNumber of employees
Employees5,461at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2022-03-3147347 pure
Pharmaceutical Businessreportable segmentemployeesat 2022-03-315149 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,724
ItemContextValueUnit
Number of employeesPrior3YearInstant_NonConsolidatedMember5291
Number of employeesPrior2YearInstant_NonConsolidatedMember5350
Number of employeesPrior1YearInstant_NonConsolidatedMember4966
Number of employeesCurrentYearInstant_NonConsolidatedMember5149
Total shareholder returnPrior4YearInstant_NonConsolidatedMember1.026
Total shareholder returnPrior3YearInstant_NonConsolidatedMember0.933
Total shareholder returnPrior2YearInstant_NonConsolidatedMember0.736
Total shareholder returnPrior1YearInstant_NonConsolidatedMember0.900
Total shareholder returnCurrentYearInstant_NonConsolidatedMember0.841
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.159
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.100
Total return on share price indexPrior2YearInstant_NonConsolidatedMember0.996
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.415
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.443
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00919-000PharmaceuticalBusinessReportableSegmentMember47347
Number of employeesCurrentYearInstant47347
Number of employeesCurrentYearInstant_NonConsolidatedMember5149
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember42.4
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember14.2
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember11051000JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00919-000PharmaceuticalBusinessReportableSegmentMember5149
Number of employeesCurrentYearInstant_NonConsolidatedMember5149
Research and development expenses research and development activitiesCurrentYearDuration526100000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration161800000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1582252525
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1582263225
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1582252525
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1582263225
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember1
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember278
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember65
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember3778
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember1093
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember971
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember603638
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember609824
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember45
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember4413909
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember948699
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember523619
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember5437616
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember10460
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember4475341
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember15809689
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember1283625
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember0.0000
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.2792
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0600
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.0331

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass